eGastroenterology

Aims & Scope

eGastroenterology dedicates itself to improving clinical diagnosis and treatment of gastrointestinal, hepatobiliary, pancreatic, and esophageal diseases.

The main aim of eGastroenterology is to provide a platform for communication among researchers and clinicians engaged in the fields of basic, clinical, and translational medicine research in gastroenterology and hepatology.

The ultimate goal is to promote the translation of basic science into clinical practice and to benefit patients through the best scientific evidence available. eGastroenterology publishes up-to-date research of prevention, diagnosis, and treatment advances in all sub-fields of digestive medicine and surgery with: • Original research • Review • Short report • Guideline • Editorial • Perspective Topics of interest include, but are not limited to, the following: • Liver diseases o Viral hepatitis o MASLD/NAFLD o Alcohol-related liver diseases o Cholestatic and biliary diseases • Hepatobiliary and pancreatic cancer • Pancreas diseases • Esophageal diseases • Hepato-pancreato-biliary surgery • Translational gastroenterology and hepatology • Gastrointestinal disorders o Irritable bowel syndrome o Gut microbiota o Inflammatory bowel disease o GI cancer • Gastrointestinal endoscope • Gut immunity • Nutrition • Gastrointestinal surgery • Epidemiology

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Alcohol-associated bowel disease: new insights into pathogenesis

  Citation: 36

  Authors: Luca, Yaojie, Yves, Isabelle, Peter, George, Bin

• Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease

  Citation: 35

  Authors: Hui, Yanchao, Ge, Nazmul, Themis, Zhihong, Suthat, Jing

• Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles

  Citation: 30

  Authors: Stephen, Héléne Toinét

• Spatial dimension of macrophage heterogeneity in liver diseases

  Citation: 22

  Authors: Adrien, Frank

• Horizon scanning: new and future therapies in the management of inflammatory bowel disease

  Citation: 22

  Authors: Aditi, Philip J

• Mechanisms of liver fibrosis in metabolic syndrome

  Citation: 21

  Authors: Wajahat

• Bile acids regulation of cellular stress responses in liver physiology and diseases

  Citation: 21

  Authors: Tiangang, Mohammad Nazmul, Lijie

• Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions

  Citation: 14

  Authors: Robert D, Thisun, Sabrina, Fan, Susan J, Alex, Mark G, Peter R, Miles P, Georgina L

• Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis

  Citation: 14

  Authors: Jianghua, Dan-Qin, Giovanni, Christopher, Byung-wan, Masahide, Seung Up, Xuhong, Gian Paolo, Michio, Masato, Ning-Jian, Herbert, Ming-Hua

• Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies

  Citation: 13

  Authors: Arthur, Fouad